As scrutineer appointed for the purpose of the Poll taken at the Annual General Meeting of the Members of the Company held on 27 June 2023, I HEREBY CERTIFY that the result of the Poll is correctly set out as follows;
Res No.
Votes For
%
Votes Against
%
Votes Total
% I.S.C.
Votes Withheld
01
219,368,131
98.50%
3,332,125
1.50%
222,700,256
63.47
7,500
02
221,329,260
99.38%
1,378,496
0.62%
222,707,756
63.47
0
03
176,757,119
79.71%
44,993,637
20.29%
221,750,756
63.20
957,000
04
217,922,400
97.85%
4,777,856
2.15%
222,700,256
63.47
7,500
05
219,358,724
98.50%
3,333,897
1.50%
222,692,621
63.46
15,135
06
222,663,346
99.99%
27,983
0.01%
222,691,329
63.46
16,427
07
218,744,926
99.71%
628,383
0.29%
219,373,309
62.52
3,334,447
08
221,024,267
99.24%
1,683,489
0.76%
222,707,756
63.47
0
Yours faithfully,
Jamie-Leah Taylor
Client Relationship Lead
Attachments
Original Link
Original Document
Permalink
Disclaimer
Creo Medical Group plc published this content on 27 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 July 2023 16:16:01 UTC.
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
CREO MEDICAL GROUP PLC 
